Immix Biopharma, Inc. (IMMX) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$29.44M | -36.2% |
| 2024 | -$21.61M | -40.1% |
| 2023 | -$15.43M | -87.4% |
| 2022 | -$8.23M | +66.2% |
| 2021 | -$24.38M | -2024.3% |
| 2020 | -$1.15M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$29.44M | -36.2% |
| 2024 | -$21.61M | -40.1% |
| 2023 | -$15.43M | -87.4% |
| 2022 | -$8.23M | +66.2% |
| 2021 | -$24.38M | -2024.3% |
| 2020 | -$1.15M | — |